White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation

Body fluid biomarkers have great potential for different clinical purposes, including diagnosis, prognosis, patient stratification and treatment effect monitoring. This is exemplified by current use of several excellent biomarkers, such as the Alzheimer’s disease cerebrospinal fluid (CSF) biomarkers...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Alzheimers Res Ther
Prif Awduron: Teunissen, Charlotte E., Otto, Markus, Engelborghs, Sebastiaan, Herukka, Sanna-Kaisa, Lehmann, Sylvain, Lewczuk, Piotr, Lleó, Alberto, Perret-Liaudet, Armand, Tumani, Hayrettin, Turner, Martin R., Verbeek, Marcel M., Wiltfang, Jens, Zetterberg, Henrik, Parnetti, Lucilla, Blennow, Kaj
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2018
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5855933/
https://ncbi.nlm.nih.gov/pubmed/29544527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0359-x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg